Fulltext

The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma

Haerle, S. ; Soyka, M. ; Fischer, D. ; Murer, K. ; Strobel, K. ; Huber, G. ; Holzmann, D.

In: European Archives of Oto-Rhino-Laryngology, 2012, vol. 269, no. 1, p. 127-133

Ajouter à la liste personnelle
    Titre
    • The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma
    Auteur
    • Haerle, S.. Department of Otolaryngology-Head and Neck Surgery, University Hospital Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland
    • Soyka, M.. Department of Otolaryngology-Head and Neck Surgery, University Hospital Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland
    • Fischer, D.. Department of Nuclear Medicine, University Hospital Zurich, 8091, Zurich, Switzerland
    • Murer, K.. Department of Otolaryngology-Head and Neck Surgery, Kantonsspital St. Gallen, 9000, St. Gallen, Switzerland
    • Strobel, K.. Department of Nuclear Medicine, University Hospital Zurich, 8091, Zurich, Switzerland
    • Huber, G.. Department of Otolaryngology-Head and Neck Surgery, University Hospital Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland
    • Holzmann, D.. Department of Otolaryngology-Head and Neck Surgery, University Hospital Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • European Archives of Oto-Rhino-Laryngology, 2012, vol. 269, no. 1, p. 127-133. Springer-Verlag
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:316143
    Summary
    The aim this study was to evaluate imaging findings using position emission tomography (PET) in combination with computed tomography (CT) and 18F-fluorodeoxyglucose (18F-FDG) in sinonasal malignant melanoma (SNMM) of the head and neck in a retrospective analysis of a consecutive cohort of patients. 18F-FDG-PET/CT examinations were performed for initial staging and compared with CT or magnetic resonance tomography (MRI), and 18F-FDG-PET alone. Medical records were reviewed retrospectively with regard to the location and the size of the tumor. Furthermore, locoregional and distant metastases with a consecutive change in therapy detected by 18F-FDG-PET/CT were assessed. Ten patients suffering from sinonasal malignant melanoma were staged and followed by 18F-FDG-PET/CT imaging. A total of 34 examinations were obtained. 18F-FDG-PET/CT depicted all primary tumors adequately. Aside from one cerebral metastasis all regional and distant metastases were truly identified by using this method. In summary, if available, 18F-FDG-PET/CT is a valuable imaging modality for staging and re-staging sinonasal malignant melanoma to evaluate expansion of the primary tumor, locoregional disease, and distant metastases